Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
UBS
Express Scripts
Mallinckrodt
Medtronic
Healthtrust
Daiichi Sankyo
Deloitte
Boehringer Ingelheim
Fish and Richardson

Generated: August 21, 2017

DrugPatentWatch Database Preview

Estramustine phosphate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for estramustine phosphate sodium and what is the scope of estramustine phosphate sodium freedom to operate?

Estramustine phosphate sodium
is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for estramustine phosphate sodium. One supplier is listed for this compound.

Summary for Generic Name: estramustine phosphate sodium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list21
Clinical Trials: see list3,113
Patent Applications: see list2,002
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:estramustine phosphate sodium at DailyMed

Pharmacology for Ingredient: estramustine phosphate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
EMCYT
estramustine phosphate sodium
CAPSULE;ORAL018045-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fish and Richardson
Moodys
AstraZeneca
Chinese Patent Office
Fuji
Novartis
Mallinckrodt
Daiichi Sankyo
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot